LB4330

· L & L Bio Co., Ltd.

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for LB4330, covering 2025-09-11 to 2025-09-17. Get the full timeline:

Most recent: Clinical Trial Update: Efficacy and Safety of LB1410 Plus Lenvatinib With or Without LB4330 in Advanced Recurrent/Metastatic Cervical Cancer [Phase 2, Phase 3]

See pricing